Overview

Visualize. Assess. Track Crohn’s disease over time.

The PillCam™ Crohn’s platform is the only product that allows physicians to directly and minimally invasive visualize the small bowel and colon in a single procedure, potentially reducing the number of exams and making disease management more convenient.

  • 172 degree field of view (per camera)
  • No sedation
  • No radiation

Comprehensive Visualization

  • Advanced optics and innovative imaging features allow for a thorough evaluation of Crohn’s disease activity and mucosal healing
  • Adaptive Frame Rate (AFR) technology increases the rate of image capture from 4 to 35 frames per second based on the speed of the capsule

Download the latest PillCam Software Reader*

Download Now

Specifications

Indications

The PillCam™ Crohn’s capsule is intended for visualization of the small bowel and colonic mucosa.

  • It may be used in the visualization and monitoring of lesions that may indicate Crohn’s disease.
  • It may be used in the visualization and monitoring of lesions that may be a source of obscure bleeding (either overt or occult).
  • It may be used in the visualization and monitoring of lesions that may be potential causes of iron deficiency anemia (IDA).

The PillCam™ Crohn’s capsule may be used as a tool in the detection of abnormalities of the small bowel and colon. It is intended for use in adults and children from eight years of age.

Contraindications

The PillCam™ Crohn’s video capsule is contraindicated for use under the following conditions:

  • In patients with known or suspected gastrointestinal obstruction, strictures, or fistulas based on the clinical picture or pre-procedure testing and profile.
  • In patients with cardiac pacemakers or other implanted electromedical devices.
  • In patients with swallowing disorders.

Note: The procedure may involve intake of laxatives and prokinetic agents. Refer to the labeling of these agents for their contraindications.

Procedure Risk Information

The risks of the PillCam™ Crohn’s capsule include capsule retention, aspiration, and skin irritation. The risks associated with colon preparation are allergies or other known contraindications to any preparation agents or medications used for the PillCam™ Crohn’s system regimen, according to laxative medication labeling and per physician discretion. Medical, endoscopic, or surgical intervention may be necessary to address any of these complications, should they occur. After ingesting the PillCam™ Crohn’s capsule, and until the capsule is excreted, patients should not be near any source of powerful electromagnetic fields, such as one created near an MRI device. Please refer to the product user manual for detailed information.

Order Information
Order Code Description Unit of Measure Quantity
FGS-0606 PillCam™ Crohn’s Capsule Pack 1
FGS-0607 PillCam™ Crohn’s Capsule Pack 5
FGS-0608 PillCam™ Crohn’s Capsule Pack 10

Specifications

Indications

The PillCam™ Crohn’s capsule is intended for visualization of the small bowel and colonic mucosa.

  • It may be used in the visualization and monitoring of lesions that may indicate Crohn’s disease.
  • It may be used in the visualization and monitoring of lesions that may be a source of obscure bleeding (either overt or occult).
  • It may be used in the visualization and monitoring of lesions that may be potential causes of iron deficiency anemia (IDA).

The PillCam™ Crohn’s capsule may be used as a tool in the detection of abnormalities of the small bowel and colon. It is intended for use in adults and children from eight years of age.

Contraindications

The PillCam™ Crohn’s video capsule is contraindicated for use under the following conditions:

  • In patients with known or suspected gastrointestinal obstruction, strictures, or fistulas based on the clinical picture or pre-procedure testing and profile.
  • In patients with cardiac pacemakers or other implanted electromedical devices.
  • In patients with swallowing disorders.

Note: The procedure may involve intake of laxatives and prokinetic agents. Refer to the labeling of these agents for their contraindications.

Procedure Risk Information

The risks of the PillCam™ Crohn’s capsule include capsule retention, aspiration, and skin irritation. The risks associated with colon preparation are allergies or other known contraindications to any preparation agents or medications used for the PillCam™ Crohn’s system regimen, according to laxative medication labeling and per physician discretion. Medical, endoscopic, or surgical intervention may be necessary to address any of these complications, should they occur. After ingesting the PillCam™ Crohn’s capsule, and until the capsule is excreted, patients should not be near any source of powerful electromagnetic fields, such as one created near an MRI device. Please refer to the product user manual for detailed information.

Order Information
Order Code Description Unit of Measure Quantity
FGS-0606 PillCam™ Crohn’s Capsule Pack 1
FGS-0607 PillCam™ Crohn’s Capsule Pack 5
FGS-0608 PillCam™ Crohn’s Capsule Pack 10

Technology

Visualize with confidence

The PillCam™ Crohn’s system is a less-invasive option for assessing your patient’s disease status. Imagine, directly visualizing the small bowel and colonic mucosa in just one procedure. Your patients will appreciate its convenience, and you’ll appreciate its ability to efficiently help you assess disease activity.1

  • Exclusive Adaptive Frame Rate (AFR) technology, which adjusts the rate of image capture to 4 or 35 FPS, depending on the movement speed
  • PillCam™ Crohn's is a minimally invasive procedure and is well tolerated by patients1
  • No sedation or radiation required1
  • The PillCam™ Crohn’s system may reduce the number of invasive procedures, which may help to increase your patients’ satisfaction1

Efficient Assessment of disease activity

The PillCam™ Crohn’s system enables you to efficiently assess your patient’s Crohn’s disease and how well it is responding to treatment.1  

Here's how: 

  • Compare images and disease progression over time  
  • Catalog prescriptions by keeping track of patient medications 
  • See severity by location
  • Tailor your approach according to your patient’s specific disease state
  • Aid physicians in the assessment of mucosal healing 
     — a hallmark of Crohn’s disease remission

How PillCamTM can help during COVID-19

Alleviate burden

Support efficient patient management

We know that determining whether to perform an urgent procedure is a complex decision under today’s circumstances. PillCam™ capsule endoscopy can help your decision-making process and offer several benefits.

Project WOW

Medtronic collaboration with the NHS

Discover how Covid-19 resulted in the creation of Project WOW, to assist the NHS deal with large number of endoscopy backlog. 

 

20 Years. 20 Stories.

Commited to continuous innovation

Celebrate with us the 20 year milestone. This is only the beginning.

  • * Allows video reviewing and reporting, but not video creation. 

  • 1. Bruining DH, Oliva S, Fleisher MR, Fischer M, Fletcher JG. Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn's disease: a multicentre, prospective study. BMJ Open Gastroenterol. 2020;7(1) ‎4

  • 2. Eliakim R, Spada C, Lapidus A, et al. Evaluation of a new pan-enteric video capsule endoscopy system in patients with suspected or established inflammatory bowel disease - feasibility study. Endosc Int Open. 2018;6(10):E1235-E1246.‎2